These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
449 related items for PubMed ID: 1317282
1. In vitro activity of sparfloxacin (CI-978), a new broad-spectrum fluoroquinolone. Qadri SM, Ueno Y, Burns JJ, Almodovar E, Rabea N. Chemotherapy; 1992; 38(2):99-106. PubMed ID: 1317282 [Abstract] [Full Text] [Related]
2. In vitro activity of CP-74667 compared with four other fluoroquinolones. Jones RN, Erwin ME. Diagn Microbiol Infect Dis; 1992 Aug; 15(6):531-6. PubMed ID: 1330419 [Abstract] [Full Text] [Related]
3. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds. Jones RN, Barrett MS, Erwin ME, Briggs BM, Johnson DM. Diagn Microbiol Infect Dis; 1991 Aug; 14(4):319-30. PubMed ID: 1909615 [Abstract] [Full Text] [Related]
4. Antibacterial activity of the new quinolone CI-960 (PD 127391) against clinical isolates at a major tertiary care center in Saudi Arabia. Qadri SM, Abo-Askar H, Ueno Y. Chemotherapy; 1992 Aug; 38(2):92-8. PubMed ID: 1317281 [Abstract] [Full Text] [Related]
10. Antibacterial activity of trovafloxacin against nosocomial Gram-positive and Gram-negative isolates. Cunha BA, Qadri SM, Ueno Y, Walters EA, Domenico P. J Antimicrob Chemother; 1997 Jun; 39 Suppl B():29-34. PubMed ID: 9222067 [Abstract] [Full Text] [Related]
11. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin. Mirelis B, Navarro F, Miró E, Coll R, Xicota MA, Prats G. Drugs Exp Clin Res; 1995 Jun; 21(4):129-38. PubMed ID: 8529525 [Abstract] [Full Text] [Related]
12. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials. Qadri SM, Lee GC, Ellis ME. Chemotherapy; 1991 Jun; 37(3):166-74. PubMed ID: 1889304 [Abstract] [Full Text] [Related]
13. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci. Rotstein C, Amsterdam D, Beam TR, Mandell LA, Gorzynski EA. Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375 [Abstract] [Full Text] [Related]
14. In vitro activity of CP-99,219, a novel 7-(3-azabicyclo[3.1.0]hexyl) naphthyridone antimicrobial. Gootz TD, Brighty KE, Anderson MR, Schmieder BJ, Haskell SL, Sutcliffe JA, Castaldi MJ, McGuirk PR. Diagn Microbiol Infect Dis; 1994 Aug; 19(4):235-43. PubMed ID: 7851087 [Abstract] [Full Text] [Related]
15. In vitro activity of the new fluoroquinolone CP-99,219. Neu HC, Chin NX. Antimicrob Agents Chemother; 1994 Nov; 38(11):2615-22. PubMed ID: 7872757 [Abstract] [Full Text] [Related]
16. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone. Marshall SA, Jones RN. Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948 [Abstract] [Full Text] [Related]